Publication | Closed Access

Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model

ImmunologyPathologyCyp2d6 Mouse ModelFatty Liver DiseaseCirrhosisAutoimmune Liver DiseaseInflammationMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseHepatotoxicityHealth SciencesMetabolic Associated SteatohepatitisAutoimmune DiseaseLiver PhysiologyAutoimmunityDrug-induced Liver InjuryHepatologyHepatitisLiver DiseaseMedicineAutoimmune Hepatitis